Positive pharmacokinetic effect of azathioprine co-medication on infliximab trough levels is dose-dependent-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Positive pharmacokinetic effect of azathioprine co-medication on infliximab trough levels is dose-dependent

Published:2019-08 Issue:8 Volume:51 Page:1112-1116
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Polakovicova Veronika,Kadleckova Barbora,Lucenicova Jana,Otottova Katarina,Kinova Sona,Mikus Peter,Zelinkova Zuzana

Funder

Slovak Research and Development Agency

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Infliximab, azathioprine, or combination therapy for Crohn’s disease;Colombel;N Engl J Med,2010

2. Sustained improvement in health-related quality of life measures in patients with inflammatory bowel disease receiving prolonged anti-tumor necrosis factor therapy;Sherman;J Dig Dis,2014

3. Review article: loss of response to anti-TNF treatments in Crohn’s disease;Ben-Horin;Aliment Pharmacol Ther,2011

4. Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis;Khan;Am J Gastroenterol,2011

5. Loss of response to anti-TNFs: definition, epidemiology, and management;Roda;Clin Transl Gastroenterol,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of Endoscopic Healing and Durability between Combination Therapy with Infliximab and Azathioprine versus Infliximab Monotherapy in Pediatric Crohn's disease;2024-06-25

2. Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease;International Journal of Colorectal Disease;2023-02-25

3. Predictive value of infliximab trough levels in maintenance therapy for 5-year sustained clinical remission in patients with inflammatory bowel disease;Bratislava Medical Journal;2023

4. Combination therapy in inflammatory bowel disease: Current evidence and perspectives;International Immunopharmacology;2023-01

5. Comparison of the Pharmacokinetics of CT-P13 Between Crohn’s Disease and Ulcerative Colitis;Journal of Clinical Gastroenterology;2022-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3